Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
MIRA MIRA Pharmaceuticals
- 1.120
- 0.0000.00%
Close Dec 13 16:00 ET
- 1.150
- +0.030+2.68%
Post 20:01 ET
18.55MMarket Cap-1.62P/E (TTM)
1.142High1.080Low263.78KVolume1.130Open1.120Pre Close291.89KTurnover2.41%Turnover RatioLossP/E (Static)16.56MShares5.01052wk High5.19P/B12.28MFloat Cap0.51052wk Low--Dividend TTM10.96MShs Float7.980Historical High--Div YieldTTM5.49%Amplitude0.510Historical Low1.106Avg Price1Lot Size
MIRA Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -4.59%-1.84M | -30.74%-863.93K | 2.40%-1.05M | 19.13%-4.53M | -6.11%-1.04M | -33.94%-1.76M | 48.04%-660.81K | 47.35%-1.08M | -307.28%-5.6M | -975.44K |
| Net income from continuing operations | 43.03%-2.04M | -33.58%-1.69M | -28.09%-1.72M | -69.77%-11.98M | -328.86%-5.79M | -98.15%-3.59M | 47.75%-1.27M | 9.08%-1.34M | -224.29%-7.06M | ---1.35M |
| Other non cash items | ---- | ---- | ---- | 43,203.28%4.44M | 210,931.09%3.73M | 17,855.66%414.24K | 12,675.78%295.89K | -57.19%1.65K | -57.95%10.25K | --1.77K |
| Change In working capital | -68.87%-67.26K | 152.03%222.59K | 44.49%168.03K | 214.10%460.41K | 261.61%811.74K | -111.52%-39.83K | -389.27%-427.79K | 120.35%116.29K | -81.11%146.58K | --224.48K |
| -Change in receivables | --0 | --0 | --11.86K | ---11.86K | ---11.86K | --0 | --0 | --0 | --0 | ---- |
| -Change in prepaid assets | 113.76%22.05K | 338.19%76.71K | 197.39%58.47K | ---243.8K | -178.67%-40.99K | -7,547.57%-160.29K | 135.01%17.51K | ---60.03K | --0 | --52.1K |
| -Change in payables and accrued expense | -174.13%-89.31K | 132.76%145.88K | -44.59%97.7K | -356.13%-389.52K | -239.81%-241.01K | -65.35%120.47K | -325.03%-445.3K | 131.16%176.32K | -80.40%152.08K | --172.38K |
| -Change in other current assets | ---- | ---- | ---- | 200.00%5.5K | ---- | ---- | ---- | ---- | ---5.5K | --0 |
| -Change in other current liabilities | ---- | ---- | ---- | --1.1M | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -4.59%-1.84M | -30.74%-863.93K | 2.40%-1.05M | 19.13%-4.53M | -6.11%-1.04M | -33.94%-1.76M | 48.04%-660.81K | 47.35%-1.08M | -307.28%-5.6M | ---975.44K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -58.41%3.16M | -76.76%159.02K | -103.35%-24.34K | 179.19%8.78M | -120.26%-230.75K | 1,024.27%7.6M | 2,837.15%684.29K | -46.47%725.68K | -24.77%3.15M | 1.14M |
| Net issuance payments of debt | ---14.47K | --0 | --0 | 728.40%1.01M | 2,377.00%1.14M | --0 | -265.90%-219.54K | 272.96%86.48K | -178.79%-160K | ---50K |
| Net common stock issuance | ---- | ---- | ---- | 165.30%7.7M | -573.72%-1.35M | ---- | ---- | ---- | -35.47%2.9M | --285K |
| Net other financing activities | 103.29%47.74K | -82.41%159.02K | -103.81%-24.34K | -81.53%74.28K | -102.12%-19.15K | -548.36%-1.45M | 1,003.83%903.83K | 458.62%639.2K | 177.22%402.19K | --904K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -58.41%3.16M | -76.76%159.02K | -103.35%-24.34K | 179.19%8.78M | -120.26%-230.75K | 1,024.27%7.6M | 2,837.15%684.29K | -46.47%725.68K | -24.77%3.15M | --1.14M |
| Net cash flow | ||||||||||
| Beginning cash position | 11,275.66%2.82M | 261,478.58%3.53M | 1,211.35%4.6M | -87.51%350.98K | 3,031.20%5.87M | -96.99%24.82K | -99.94%1.35K | -87.51%350.98K | 80,379.86%2.81M | --187.42K |
| Current changes in cash | -77.40%1.32M | -3,102.96%-704.91K | -207.15%-1.07M | 272.93%4.25M | -873.87%-1.27M | 1,015.10%5.84M | 101.81%23.47K | 49.09%-349.63K | -187.62%-2.46M | --163.56K |
| End cash Position | -29.37%4.14M | 11,275.66%2.82M | 261,478.58%3.53M | 1,211.35%4.6M | 1,211.35%4.6M | 3,031.20%5.87M | -96.99%24.82K | -99.94%1.35K | -87.51%350.98K | --350.98K |
| Free cash flow | -4.59%-1.84M | -30.74%-863.93K | 2.40%-1.05M | 19.13%-4.53M | -6.11%-1.04M | -33.94%-1.76M | 48.04%-660.81K | 47.35%-1.08M | -307.28%-5.6M | ---975.44K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.